Related Experiment Video
Updated: Nov 11, 2025

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
Evaluation of early microstructural changes in the R6/1 mouse model of Huntington's disease by ultra-high field
Rodolfo G Gatto1, Carina Weissmann2, Manish Amin3
1Department of Bioengineering, University of Illinois at Chicago, Chicago, IL, USA.
Abstract:
Diffusion MRI (dMRI) has been able to detect early structural changes related to neurological symptoms present in Huntington's disease (HD). However, there is still a knowledge gap to interpret the biological significance at early neuropathological stages. The purpose of this study is two-fold: (i) establish if the combination of Ultra-High Field Diffusion MRI (UHFD-MRI) techniques can add a more comprehensive analysis of the early microstructural changes observed in HD, and (ii) evaluate if early changes in dMRI microstructural parameters can be linked to cellular biomarkers of neuroinflammation. Ultra-high field magnet (16.7T), diffusion tensor imaging (DTI), and neurite orientation dispersion and density imaging (NODDI) techniques were applied to fixed ex-vivo brains of a preclinical model of HD (R6/1 mice). Fractional anisotropy (FA) was decreased in deep and superficial grey matter (GM) as well as white matter (WM) brain regions with well-known early HD microstructure and connectivity pathology. NODDI parameters associated with the intracellular and extracellular compartment, such as intracellular ventricular fraction (ICVF), orientation dispersion index (ODI), and isotropic volume fractions (IsoVF) were altered in R6/1 mice GM. Further, histological studies in these areas showed that glia cell markers associated with neuroinflammation (GFAP & Iba1) were consistent with the dMRI findings. dMRI can be used to extract non-invasive information of neuropathological events present in the early stages of HD. The combination of multiple imaging techniques represents a better approach to understand the neuropathological process allowing the early diagnosis and neuromonitoring of patients affected by HD.
Insights
Ultra-high field diffusion MRI (dMRI) reveals early microstructural brain changes in Huntington's disease (HD) models. These changes correlate with neuroinflammation markers, aiding early diagnosis and monitoring.
Area of Science:
- Neuroimaging
- Neuroscience
- Biomedical Engineering
Background:
- Diffusion MRI (dMRI) detects early structural changes in neurological diseases like Huntington's disease (HD).
- A gap exists in understanding the biological significance of early neuropathological changes in HD.
- Neuroinflammation is implicated in the early stages of HD pathogenesis.
Purpose of the Study:
- To determine if Ultra-High Field Diffusion MRI (UHFD-MRI) enhances the analysis of early microstructural changes in HD.
- To investigate the link between early dMRI microstructural parameters and cellular biomarkers of neuroinflammation in HD.
Main Methods:
- Application of 16.7T UHFD-MRI, Diffusion Tensor Imaging (DTI), and Neurite Orientation Dispersion and Density Imaging (NODDI) on fixed ex-vivo brains of R6/1 mice (a preclinical HD model).
- Analysis of microstructural parameters including Fractional Anisotropy (FA), Intracellular Volume Fraction (ICVF), Orientation Dispersion Index (ODI), and Isotropic Volume Fraction (IsoVF).
- Histological examination of glia cell markers (GFAP & Iba1) to assess neuroinflammation.
Main Results:
- Decreased FA was observed in grey matter (GM) and white matter (WM) regions associated with early HD pathology.
- NODDI parameters (ICVF, ODI, IsoVF) were altered in the GM of R6/1 mice.
- Histological findings of glial markers (GFAP & Iba1) corroborated the dMRI-detected microstructural changes and neuroinflammation.
Conclusions:
- dMRI provides non-invasive insights into early neuropathological events in HD.
- Combining multiple dMRI techniques offers a comprehensive approach to understanding HD neuropathology.
- This approach facilitates early diagnosis and neuromonitoring of HD patients.

